BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
McKinsey
AstraZeneca
US Army
Cantor Fitzgerald
Dow
UBS
McKesson
Baxter

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,474,979

« Back to Dashboard

Summary for Patent: 5,474,979
Title: Nonirritating emulsions for sensitive tissue
Abstract:A pharmaceutical composition is disclosed in the form of a nonirritating emulsion which includes at least one cyclosporin in admixture with a higher fatty acid glyceride and polysorbate 80. More particularly, the cyclosporin may be cyclosporin A and the higher fatty acid glyceride may be castor oil. Composition has been found to be of a high comfort level and low irritation potential suitable for delivery of medications to sensitive areas such as ocular tissues. In addition, the composition has stability for up to nine months without crystallization of cyclosporin.
Inventor(s): Ding; Shulin (Irvine, CA), Tien; Walter L. (Irvine, CA), Olejnik; Orest (Trabuco Canyon, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:08/243,279
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 5,474,979

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,474,979

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 203911 ➤ Subscribe
Austria 234076 ➤ Subscribe
Australia 2640995 ➤ Subscribe
Australia 693213 ➤ Subscribe
Brazil 1101071 ➤ Subscribe
Brazil 9507664 ➤ Subscribe
Canada 2190485 ➤ Subscribe
Canada 2309033 ➤ Subscribe
China 1152876 ➤ Subscribe
China 1198587 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Cipla
AstraZeneca
Cerilliant
Covington
Merck
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot